Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Gang Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1392-7641; OpenAlex author ID A5102024875. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers

Papers 6

  1. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. Last author DOI 10.1016/j.abb.2020.108469↗
  2. TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt Last author DOI 10.1101/2020.05.29.123091↗
  3. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ. First author DOI 10.3892/or.2019.6989↗
  4. Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells. Last author DOI 10.3892/mmr.2018.9331↗
  5. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a. Co-author DOI 10.3727/096504017x14888987683152↗
  6. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Co-author PMID 25573220↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiaxun Tian · 3 shared papers, 2018–2020 · strength 0.32
  2. Xiaobo Zhang · 3 shared papers, 2017–2019 · strength 0.27
  3. Xin Wang · 2 shared papers, 2020 · strength 0.25
  4. Xiangdong Hua · 2 shared papers, 2020 · strength 0.25
  5. Xiaodong Tan · 2 shared papers, 2017–2019 · strength 0.20
  6. Weiwei Sheng · 2 shared papers, 2014–2018 · strength 0.12
  7. Jianping Zhou · 2 shared papers, 2014–2018 · strength 0.12
  8. Feng Gao · 1 shared paper, 2019 · strength 0.11
  9. Peng Liu · 1 shared paper, 2019 · strength 0.11
  10. Ming Dong · 1 shared paper, 2018 · strength 0.07
  11. Wei Sun · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.